Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,281 to 1,300 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel case of intrachromosomal amplification and insertion of RUNX1 on derivative chromosome 2 in pediatric AML. | Cancer Genet | 2021 | 33647813 | PubTator, text mining | PubMed |
| A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML. | Neoplasia | 2021 | 33621854 | PubTator, text mining | PubMed |
| What do Transcription Factors Interact With? | J Mol Biol | 2021 | 33621520 | PubTator, text mining | PubMed |
| Independent component analysis based gene co-expression network inference (ICAnet) to decipher functional modules for better single-cell clustering and batch integration. | Nucleic Acids Res | 2021 | 33619563 | PubTator, text mining | PubMed |
| Acute myeloid leukemia: current progress and future directions. | Blood Cancer J | 2021 | 33619261 | PubTator, text mining | PubMed |
| Concomitant gain and loss of function pathomechanisms in C9ORF72 amyotrophic lateral sclerosis. | Life Sci Alliance | 2021 | 33619157 | PubTator, text mining | PubMed |
| Uncovering the Pharmacological Mechanism of 2-Dodecyl-6-Methoxycyclohexa-2,5 -Diene-1,4-Dione Against Lung Cancer Based on Network Pharmacology and Experimental Evaluation. | Front Pharmacol | 2021 | 33613291 | PubTator, text mining | PubMed |
| The role of m6A modification in the biological functions and diseases. | Signal Transduct Target Ther | 2021 | 33611339 | PubTator, text mining | PubMed |
| HDN-1 induces cell differentiation toward apoptosis in promyelocytic leukemia cells depending on its selective effect on client proteins of Hsp90. | Toxicol Appl Pharmacol | 2021 | 33609515 | PubTator, text mining | PubMed |
| Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors. | J Cancer Res Clin Oncol | 2021 | 33604794 | PubTator, text mining | PubMed |
| Syngeneic leukemia models using lentiviral transgenics. | Cell Death Dis | 2021 | 33602907 | PubTator, text mining | PubMed |
| Access to patient oriented information-a baseline Endo-ERN survey among patients with rare endocrine disorders. | Endocrine | 2021 | 33599944 | PubTator, text mining | PubMed |
| Blood cancer health disparities in the United States Hispanic population. | Cold Spring Harb Mol Case Stud | 2021 | 33593728 | PubTator, text mining | PubMed |
| Chromosome 8 gain is associated with high-grade transformation in MPNST. | JCI Insight | 2021 | 33591953 | PubTator, text mining | PubMed |
| Integrating Patient-Specific Information into Logic Models of Complex Diseases: Application to Acute Myeloid Leukemia. | J Pers Med | 2021 | 33578936 | PubTator, text mining | PubMed |
| ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both? | Biomolecules | 2021 | 33573353 | PubTator, text mining | PubMed |
| Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia. | Cancers (Basel) | 2021 | 33562525 | PubTator, text mining | PubMed |
| Treatment Outcomes of Pediatric Acute Myeloid Leukemia in the Yeungnam Region: A Multicenter Retrospective Study of the Study Alliance of Yeungnam Pediatric Hematology-Oncology (SAYPH). | Children (Basel) | 2021 | 33562522 | PubTator, text mining | PubMed |
| The hemogenic endothelium: a critical source for the generation of PSC-derived hematopoietic stem and progenitor cells. | Cell Mol Life Sci | 2021 | 33559689 | PubTator, text mining | PubMed |
| Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML). | Leukemia | 2021 | 33558666 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=65